Physician profile
Britte D Smith
NPI 1053366617
$1,347.97
in general payments reported to CMS, 2019-2025
23 companies · $206 in 2025
The $206 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $135 · 2021: $328 · 2022: $103 · 2023: $134 · 2024: $275 · 2025: $206.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $616.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $615.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $410.58 | 2019-2022 | |
| Hologic Sales and Service, LLC | $106.91 | 2022-2025 | Novasure, Fluent Fluid Management System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Organon LLC | $93.94 | 2023-2025 | Nexplanon |
| Exeltis, USA INC. | $84.48 | 2021-2025 | Slynd |
| Baxter Healthcare | $83.02 | 2024 | Perclot |
| Astellas Pharma US INC | $82.78 | 2023-2025 | Veozah |
| Mayne Pharma Commercial LLC | $68.73 | 2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.98 | 2019-2021 | |
| Minerva Surgical, INC | $49.14 | 2024 | |
| Covidien Lp | $44.19 | 2019 | |
| Millicent US INC | $40.94 | 2025 | Intrarosa, Femlyv |
| Pfizer INC. | $39.53 | 2019-2022 | |
| Allergan, INC. | $23.59 | 2019-2020 | |
| Medtronic, INC. | $22.75 | 2024 | Ligasure |
| Applied Medical Resources Corporation | $20.73 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Meditrina | $18.33 | 2023 | |
| Amgen INC. | $16.58 | 2023 | Evenity |
| Roche Diagnostics Corporation | $15.86 | 2020 | |
| Sumitomo Pharma America, INC. | $13.71 | 2025 | Myfembree |
| Therapeuticsmd, INC. | $13.52 | 2019 | |
| Convatec INC. | $12.79 | 2019 | |
| Agile Therapeutics, INC. | $11.73 | 2022 | |
| Evofem Biosciences, INC. | $11.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Britte Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.